Thank you. Eko Kimobochi will give a two-lecture lecture in 15 minutes. Yes. I will start this with my presentation with stories for the long-term friendships and cooperation. I met Dr. Aida for the first time in 2017 through the ICS-SPOT team to bring her, from Dr. Jo to bring her to see us with a basic training course on the corpuscopid and dysplasia treatment in the CDCs with Dr. Quang Ngo. And after that, in the 2019, she come back and keep training us with the corpuscopids. And in the 2022s, the first time we had a conference for the updating on screening and management of the pre-cancer disease. Yeah. And Dana Oncology Hospital, she introduced us the imaging process with the ICS-SPOT's APB correlations. And I will introduce you the... Sorry, the correlates... Sorry, sorry. Sorry, a little bit for me. So it's the ASAN-specific APB correlations with experts and top leader from the ASAN-specific regions with the empathize and interest with the public health police applications and evidence based on research to in-depth ICU pertaining to the APB-related disease. This group is led by Prof. Susan Garland and Dr. Suresh Kumarathis. And on this process, the name of process is the ASES, which is Accelerating Cervical Cancer Alimentation with Cell Samplings. And the missions of the APB correlations is the tackle ICU's pertinent needs to awareness, preventance, screenings, and treatment of APB-related disease for the all, regardless of genome. You know, in the WHO data in 2019, is 570,000 women were diagnosed with cervical cancer and roughly 311,000 women died with disease. In fact, 17% of the women in the low and middle income countries have never been screened for the cervical cancer even in the timeline. And 58% of the new case are in the ASAN. So I will to show you some of the results of the cell sampling data. So the results show us the cell sampling data is the safe and sensitive of the physical collecting cervical cancer. So the WHO had the recommendations for the screenings with APB as a primary screening test. And now they add in the recommendation with the APB cell sampling is improve the screening for the cervical cancer. And I will introduce the user roles for foundations is the non-profit organizations as the place in the 2019 to committees to eliminating the cervical cancer in Malaysia with our in-house library and community outreach initiative. The program roles offer the women to comprehend cervical screenings, our approach to their approach to the cell sampling. So primary APB testing is the mobilized based on digital health platform and physical lesions, then please follow up and link up to care and the treatment if required. Thank you. So we, so the hours of protest to the study right to know to the five-year processings of mental research pilots to imply two months study with Mongols and Sri Lankans and Vietnam. The studies aim to introduce APB testing using the cell sampling with a common block swap and screening draw map using the current legible cost it pays to the trees, now middle income country is the ASM Pacific region with the priorities cervical screenings. The press using the protest will to identify barriers and for police station to completing cervical screenings pathway from the first phase of the woman's profile and communities and spark holder understandings and attitude related to the APB's basings of primary cervical screenings and cell collection. And we develop things and implement and ever locations the innovations APB based on the cell testing model including the path facilities and communication based in strikings and linker to carrying the pathway using the mobile software techniques. The, we, we will to perform the cost effective and both get in fast, the analyze tool under different implementations and a scale of screening. We, the studies metal piece selected it allows middle income countries with light Montalinga, Sri Lanka and Danang and Montaliga and Sri Lanka was chosen for having some infrastructure already in place for the screenings. So because screening, why the Danang we have a very limited infrastructure for this. So, but three of us to announce implements of the APB DNA testing by the self-disciplines is a part of the screening strategy. The findings of this study will be targeted to men, the straight holder in the low middle income countries as a initial guiding to the catalyzed elegance between the healthcare professional and the public and politics maker to implement to more release this achievable, cause a fast co-conscious and sustainable cervical cancer screening program using the APB DNA testing by a cell sampling with a carbon block spot, the incorporated into the development screening to trace the roadmap developed by the system. So we just pass the first step and in the, and we will run me up the two step to the discussing with the MPAC with the Asian Pacific APB College Nations. And we will to establish and convent a professional advisors group. We will to prepare agents for funding applications and absolutely the more and more memorandum of the understanding. The breadth will be started in the end of 2024 prepare patient for study site by the end of the 2025. And the data collection is the end of 2026 or early in 2027. These are projects timeline. We can see, we chose a path in the year one and we will to keep on to the year two and year one and year two in the next year. And we propose the, but yes, we on total set of costs for the five year studies is roughly 600,000. So it's a lot of money. So we have a way to discuss with the MPAC to get projects is working. And I will to save the last four blessings with my team to Dr. Yung and Dr. Ngoc to have the study for the APBs in the Danang Autonomous Rehabilitation Hospital. APB testing in the Danang Autonomous Rehabilitation Hospital. We say publish the results on the IGZ meeting in the poster. And the last is not least is the amazing workshop I have been in this year, the IGZ Prevent Disease Program with Dr. Ida and Dr. Mila. I will to thank you the IGZ to help us and to bring us to keep continue the prevent of the cervical cancer. And we have to work with you in the future. Thank you.

cervical cancer screening

APB cell sampling

non-profit organization

cervical cancer elimination

IGZ support